Gurdip Bhalay

Gurdip Bhalay joined the Institute of Cancer Research, London, as Faculty and Project Leader of Medicinal Chemistry in 2018, within the Centre for Cancer Drug Discovery, where his group is involved in collaborative research with both internal and external partners. Gurdip studied chemistry at Nottingham University, completing his Ph.D. with Professor Ray Jones, before moving to Oxford University for postdoctoral work with Professor Steve Davies. After this he joined Oxford Diversity (now part of Evotec) then moved to Novartis, where he spent the next 16 years contributing to and leading drug discovery projects which resulted in the discovery of clinical candidates. His last position was at Charles River Early Discovery giving him further project leadership experience and commercial awareness in managing projects.